How ractopamine binds to bovine serum albumin at the drug site 1

Ractopamine (RAC) is a common -agonist often used as a feed additive to improve muscle mass in farm animals. However, RAC has been banned in several countries due to its toxicity. To date, no clear evidence shows pharmacological and poisonous adverse effect of RAC in farm animals. In beef cattle, al...

Full description

Saved in:
Bibliographic Details
Published in:Molecular simulation 2023-04, Vol.49 (6), p.599-607
Main Authors: Janoon, Kanokwan, Kuntip, Nattapon, Niramitranon, Jitti, Pongprayoon, Prapasiri
Format: Article
Language:English
Subjects:
Animals
Binding sites
Bioavailability
Bovine serum albumin
BSA
Cattle
Fatty acids
Food additives
HSA
MD simulations
Molecular dynamics
Muscles
Naproxen
ractopamine
Serum albumin
Toxicity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ractopamine (RAC) is a common -agonist often used as a feed additive to improve muscle mass in farm animals. However, RAC has been banned in several countries due to its toxicity. To date, no clear evidence shows pharmacological and poisonous adverse effect of RAC in farm animals. In beef cattle, although RAC can be carried by bovine serum albumin (BSA) at drug site I, its effect on BSA structure and function remains unclear. Thus, in this work, Molecular Dynamics (MD) Simulations were employed to explore the binding interactions of RAC to BSA. Seemingly, RAC causes the high flexibility of domains I and III and importantly induces the large expansion of drug site II's cavity which can interfere the drug-binding ability of drug site II. RAC binds to drug site I close to subdomain IIA, which is the same naproxen-binding site. Like naproxen, a polar moiety of RAC interacts with R194, R198 and W213. Our results reveal the RAC intrusion into the fatty acid site 6 (FA6) which implies the connection between drug site I and FA6 site. An insight into the RAC-BSA binding here can act as a base to better understand a drug distribution and bioavailability in cattle.
ISSN:0892-7022
1029-0435
DOI:10.1080/08927022.2023.2178239